Coloplast A/S experienced notable insider activity in March 2026, with three executives and board members acquiring shares. CFO Anders Lonning-Skovgaard, alongside directors Niels B. Christiansen and Carsten Hellmann, executed significant purchases between March 5 and March 10. These transactions represent a collective investment of approximately 5 million DKK, reflecting recent leadership confidence.